Adoption allows ICON to take full advantage of the Medidata "Data Experience," leveraging AI to unify data sources, standardize outputs, and reduce reconciliation efforts NEW YORK, March 20, 2025 ...

and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across 2,100+ customers trust Medidata’s seamless, end-to-end platform to ...

“With the maturation of the clinical data set, it becomes progressively evident for me that targeting PRAME with Immatics’ IMA203 TCR-T approach has the potential to provide a durable benefit ...

Icon could fail to innovate and keep an edge over regional and global CRO competitors, especially as data and analytics play an increasing role in clinical development. Icon is taking on a lot of ...

and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across approximately 2,200 customers trust Medidata’s seamless, end-to-end ...

We recently compiled a list of the Top 8 Trending AI Stock Updates On Wall Street Today. In this article, we are going to take a look at where ICON Public Limited Company (NASDAQ:ICLR) stands ...

As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired ...

But for all the rapid advances in science and medicine, some of the building blocks of clinical trials — the back-end technology, data aggregation ... officer of Icon, a company that arranges ...

For example, AI can be used to aid doctors with their clinical decisions, find new tumor types in large research data sets, enhance the accuracy of diagnostic tests and improve hospital operations.